Phenaris

Phenaris is a partner of the recently established EU-ToxRisk Commercial Platform for New Approach Methods (NAMs) in Safety Assessment

At Phenaris we constantly challenge the status quo in computational drug design and in silico toxicology.

Using cutting edge technologies we provide data, models, and decision support in all aspects of in silico toxicology. We are currently working on multiple solutions to provide data integration, model development, and decision support.

https://www.phenaris.com/

Latest Tweets

Edelweiss Connect (Yesterday)
Tuesday, January 26, 16 CET #SaferWorldbyDesign webinar - Cellenion will present its solutions for single-cell anal… https://t.co/VLjDHCe3VX
Edelweiss Connect (Yesterday)
RT @barryhardy: Comparison of 2D vs 3D Single Cell Transcriptomic Analyses Consider to signup for this week’s #SaferWorldbyDesign webinar…
Edelweiss Connect (2 weeks ago)
Join us for our first 2021 #webinar with #SaferWorldbyDesign partner @wepredic Prediction of the cholestatic pote… https://t.co/rXfvcHEfTT
Edelweiss Connect (2 months ago)
Join us for the upcoming #SaferWorldbyDesign webinar Validated HepaRG™ mechanistic methods as a tool for dynamic a… https://t.co/jQJSMIwWB3
Edelweiss Connect (3 months ago)
RT @barryhardy: Communicating cell culturing protocol knowledge - initial #HepaRG examples available on #saferworldbydesign https://t.co/O…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA